Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells

References

• Wellington K, Jarwis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001;15:465–489.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Jiang YY, Wei XF, Huang H, Tashiro S, Onodera S, Ikejima T. Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells. Free Radic Res 2010;44:90–100.
   PubMed Web of Science ®Google Scholar
• Wang Y, Marsden PA. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 1995;34:71–90.
   PubMedGoogle Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996;271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Tashiro S, Onodera S, Ikejima T. Inhibition of insulin-like growth factor 1 receptor signaling enhanced silibinin-induced activation of death receptor and mitochondrial apoptotic pathways in human breast cancer MCF-7 cells. J Pharmacol Sci 2008;107:260–269.
   PubMed Web of Science ®Google Scholar
• Boveris A, Costa L, Cadenas E, Poderoso JJ. Regulation of mitochondrial respiration by adenosine phosphate, oxygen, and nitric oxide. Methods Enzymol 1999;301:188–198.
   PubMed Web of Science ®Google Scholar
• Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994;308:89–95.
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K, Bauer MK, Vogt M, Wesselborg S. Oxidative stress and signal transduction. Int J Vitam Nutr Res 1997;67:336–342.
   PubMed Web of Science ®Google Scholar
• Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997;22:1115–1126.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems and apoptosis. Free Radic Biol Med 2010;48:749-762.
   PubMed Web of Science ®Google Scholar
• Ma Q. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther 2010;125:376–393.
   PubMed Web of Science ®Google Scholar
• Groeger G, Quiney C, Cotter TG. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009;11:2655–2671.
   PubMed Web of Science ®Google Scholar
• Gupta A, Rosenberger SF, Bowden GT. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 1999;20:2063–2073.
   PubMed Web of Science ®Google Scholar
• Sulston J, Hodgkin J. Methods. Wood WB. The nematode caenorhabditis elegans. New York: Cold Spring Harbor Laboratory Press; 1988. 587–606.
   Google Scholar
• Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997;272:4959–4963.
   PubMed Web of Science ®Google Scholar
• Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 1991;5:98–103.
   PubMed Web of Science ®Google Scholar
• Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007;6:662–680.
   PubMed Web of Science ®Google Scholar
• Packer MA, Porteous CM, Murphy MP. Mitochondrial superoxide production in the presence of nitric oxide leads to the formation of peroxynitrite. Biochem Mol Biol Int 1996;40:527–534.
   PubMedGoogle Scholar
• Cabello CM, Bair WB 3rd, Wondrak GT. Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr Opin Investig Drugs 2007;8:1022–1037.
   PubMedGoogle Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009;8:579–591.
   PubMed Web of Science ®Google Scholar
• Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95.
   PubMed Web of Science ®Google Scholar
• Chuang CH, Huang CS, Hu ML. Vitamin E and rutin synergistically inhibit expression of vascular endothelial growth factor through down-regulation of binding activity of activator protein-1 in human promyelocytic leukemia (HL-60) cells. Chem Biol Interact 2010;183:434–441.
   PubMed Web of Science ®Google Scholar
• Lee JA, Song HY, Ju SM, Lee SJ, Kwon HJ, Eum WS, Jang SH, Choi SY, Park JS. Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells. Exp Mol Med 2009;41:629–637.
   PubMed Web of Science ®Google Scholar
• Jourd'heuil D. Increased nitric oxide-dependent nitrosylation of 4,5-diaminofluorescein by oxidants: implications for the measurement of intracellular nitric oxide. Free Radic Biol Med 2002;33:676–684.
   PubMed Web of Science ®Google Scholar
• Poderoso J, Carreras M, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996;328:85–92.
   PubMed Web of Science ®Google Scholar
• Poderoso JJ, Peralta J, Lisdero C, Carreras M, Radisic M, Schopfer F, Cadenas E, Boveris A. Nitric oxide regulates oxygen uptake and hydrogen peroxide release by the isolated beating rat heart. Am J Physiol 1998;274:C112–C119.
   PubMed Web of Science ®Google Scholar
• Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett 1994;345:50–54.
   PubMed Web of Science ®Google Scholar